Atherotech Diagnostics Lab Lab Adds Genetic Testing to Optimize Cardiovascular Disease Treatment and Outcomes

Published: Jul 25, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Atherotech Diagnostics Lab, a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions, has added three new genetic tests to its cardiometabolic test offering: warfarin sensitivity, Plavix® sensitivity and the thrombophilia risk test.

Help employers find you! Check out all the jobs and post your resume.

Back to news